CADL — Candel Therapeutics, Inc. stock price, charts and financials

QT85Candel Therapeutics, Inc.

Candel Therapeutics, Inc. (NASDAQ: CADL) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
10.51
+0.44+4.37%
OverviewShort InterestFilings
CADLQT85Candel Therapeutics, Inc.·NASDAQ
10.51+4.37%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 27, 2026SC 13GBeneficial ownership statement (passive)
Jul 08, 20263Initial statement of beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20268-KCurrent report
Jun 24, 20264Statement of changes in beneficial ownership
Jun 16, 20268-KCurrent report
May 15, 20268-KCurrent report
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 14, 20268-KCurrent report
May 14, 202610-QQuarterly report
Apr 29, 2026ARSAnnual report to shareholders
Apr 29, 2026DEF 14ADefinitive proxy statement
#1 / 25 of 358
Page
▼
/ 15